Bausch & Lomb Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Bausch & Lomb Corp (BLCO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.32 million shares for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2024-10-30
- Bausch & Lomb Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Bausch & Lomb Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Bausch & Lomb Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-03-31 was 1.32M shares, a 50.84% decline year-over-year.
- Bausch & Lomb Corp share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 323.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | 0.00 shares derived: sum of 2 quarters · filed 2024-10-30 | 1.32M shares 10-Q · filed 2024-10-30 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 1.32M shares 10-Q · filed 2024-08-01 | |
| 2024-03-31 | 1.32M shares 10-Q · filed 2024-05-01 | ||
| 2023-09-30 | 323.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | 774.00K shares derived: sum of 2 quarters · filed 2024-10-30 | 3.45M shares 10-Q · filed 2024-10-30 |
| 2023-06-30 | 451.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 3.13M shares 10-Q · filed 2024-08-01 | |
| 2023-03-31 | 2.68M shares 10-Q · filed 2024-05-01 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | 6.46M shares derived: sum of 2 quarters · filed 2023-11-01 | 6.46M shares 10-Q · filed 2023-11-01 |
| 2022-06-30 | 6.46M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 6.46M shares 10-Q · filed 2023-08-02 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |